Literature DB >> 457276

Inhibition of macrophage migration by muramyl peptides.

S Nagao, A Tanaka, Y Yamamoto, T Koga, K Onoue, T Shiba, K Kusumoto, S Kotani.   

Abstract

In the capillary tube migration system a synthetic muramyl dipeptide (MDP; N-acetylmuramyl-L-alanyl-D-isoglutamine), a part of bacterial cell wall peptidoglycans, inhibited the migration of peritoneal exudate macrophages from normal guinea pigs or rats. The migration inhibition was also caused by some MDP-containing peptidoglycan fragments from cell walls of Lactobacillus plantarum and Staphylococcus epidermidis. The migration inhibition could not be explained on the basis of macrophage migration inhibitory factor. A stereochemically highly specific structure of MDP required for its adjuvant activity was also required for the macrophage migration inhibition. These findings suggest that MDP and MDP-containing cell wall fragments may activate macrophages and that this activation may be important in the exertion of their adjuvant activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457276      PMCID: PMC414302          DOI: 10.1128/iai.24.2.308-312.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

2.  Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity.

Authors:  A Tanaka; S Nagao; R Saito; S Kotani; S Kusumoto; T Shiba
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

3.  Regulation of endotoxin-induced inhibition of macrophage migration by fresh serum.

Authors:  D H Heilman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

4.  Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues.

Authors:  H Takada; S Kotani; S Kusumoto; Y Tarumi; K Ikenaka
Journal:  Biken J       Date:  1977-06

5.  Nonspecific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine).

Authors:  C Damais; M Parant; L Chedid
Journal:  Cell Immunol       Date:  1977-11       Impact factor: 4.868

6.  Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. II. Analysis of the macrophage-replacing activity of the LPS-stimulated macrophage culture supernatant in the antigenic activation of purified immune lymphocytes.

Authors:  M Ohishi; K Onoue
Journal:  Cell Immunol       Date:  1976-10       Impact factor: 4.868

7.  Inhibition of macrophage migration by synthetic muramyl dipeptide.

Authors:  Y Yamamoto; S Nagao; A Tanaka; T Koga; K Onoue
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

8.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

10.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  30 in total

1.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

2.  Epithelioid granuloma induced by muramyl dipeptide in immunologically deficient rats.

Authors:  S Nagao; F Ota; K Emori; K Inoue; A Tanaka
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

3.  Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Authors:  Y Osada; T Otani; M Sato; T Une; K Matsumoto; H Ogawa
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch.

Authors:  H Kiyono; J R McGhee; M J Wannemuehler; M V Frangakis; D M Spalding; S M Michalek; W J Koopman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  Epithelioid granuloma formation requiring no T-cell function.

Authors:  A Tanaka; K Emori; S Nagao; K Kushima; O Kohashi; M Saitoh; T Kataoka
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

7.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in mice.

Authors:  B Wuest; E D Wachsmuth
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Possible chemotaxis of human monocytes by N-acetylmuramyl-L-alanyl-D-isoglutamine.

Authors:  T Ogawa; S Kotani; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Polymorphonuclear neutrophil chemotaxis modulated by Bacteroides fragilis peptidoglycan.

Authors:  J F Sperry; J M Burns
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.